Cargando…
Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials
OBJECTIVES: The COVID-19 pandemic necessitates time-sensitive policy and implementation decisions regarding new therapies in the face of uncertainty. This study aimed to quantify consequences of approving therapies or pursuing further research: immediate approval, use only in research, approval with...
Autores principales: | Dijk, Stijntje W., Krijkamp, Eline M., Kunst, Natalia, Gross, Cary P., Wong, John B., Hunink, M.G. Myriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045876/ https://www.ncbi.nlm.nih.gov/pubmed/35490085 http://dx.doi.org/10.1016/j.jval.2022.03.016 |
Ejemplares similares
-
Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study
por: Gravesteijn, Benjamin, et al.
Publicado: (2021) -
Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China
por: Ma, Siyu, et al.
Publicado: (2020) -
Where Do We Go From Here? A Framework for Using Susceptible-Infectious-Recovered Models for Policy Making in Emerging Infectious Diseases
por: Zawadzki, Roy S., et al.
Publicado: (2021) -
“Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs
por: Cheung, Douglas C., et al.
Publicado: (2022) -
Determinants of Face Mask Utilization to Prevent Covid-19 Pandemic among Quarantined Adults in Tigrai Region, Northern Ethiopia, 2020
por: Haftom, Mekonnen, et al.
Publicado: (2021)